Patient advocates are working with Congressional staff to revise proposed federal “Right to Try” legislation that would prohibit the US FDA from taking any action to restrict compassionate use programs in the 34 states that allow it.
Opponents to the measure – including Friends of Cancer Research, the American Cancer Society and the National Organization for Rare...







